Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients

被引:0
作者
Shibata, N [1 ]
Hoshino, N
Minouchi, T
Yamaji, A
Park, K
Tomoyoshi, T
Abe, H
Kodama, M
机构
[1] Shiga Univ Med Sci, Dept Hosp Pharm, Otsu, Shiga 52021, Japan
[2] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga 52021, Japan
[3] Shiga Univ Med Sci, Dept Surg 1, Otsu, Shiga 52021, Japan
关键词
cyclosporin A; AUC monitoring; trough level monitoring; renal transplant patients; pharmacokinetics;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We evaluated the relationship between the area under the concentration versus time curve (AUG) of cyclosporin A (CsA) and several other clinical factors, because the clinical utility of AUC monitoring has been ambiguous. Fifty-four clinical time courses from 14 Japanese renal transplant patients during hospitalization, in the period from April 1990 to March 1997, were examined. In a bivariate regression analysis there was no correlation between the AUC and the daily dose of CsA (mg/kg/day) when the individual data or total series data were analyzed. In a chi-square test, the donor type of kidney (chi(2) = 25.254, df = 1, p = 0.0000) and renal function-related episodes, i.e. acute tubular necrosis, hemodialysis, hypertension, nephrotoxicity, or rejection (chi(2) = 13.982, df = 1, p = 0.0002) directly affected posttransplant renal function assessed by creatinine clearance, while episodes of hepatic function as assessed by the glutamate-pyruvate transaminase (GPT) activity level had no correlation with the posttransplant renal function evaluated according to creatinine clearance. In contrast, the renal function-related episodes significantly affected the AUC after renal transplantation (chi(2) = 4.934, df = 1, p = 0.0263), while hepatic function assessed by GPT did not. In a multivariate analysis, the creatinine clearance and obesity had signifcant positive correlations with the AUG, whereas the hematocrit had a significant negative correlation with the AUC. From these observations, we concluded that the dosage adjustment of CsA cannot be performed using the linear relationship between the daily oral dose and the AUG, and that renal function, obesity, and the CsA blood distribution properties affect the CsA pharmacokinetics after renal transplantation. Posttransplant renal function as well as obesity and CsA blood distribution properties are important factors to be considered when therapeutic monitoring is performed.
引用
收藏
页码:202 / 209
页数:8
相关论文
共 33 条
[1]  
ATKINSON K, 1984, BRIT J HAEMATOL, V56, P223, DOI 10.1111/j.1365-2141.1984.tb03950.x
[2]   THE EFFECTS OF AGE AND DOSAGE ROUTE ON EXPERIMENTAL CYCLOSPORINE NEPHROTOXICITY [J].
BENNETT, WM ;
LINDSLEY, J ;
BUSS, WC .
TRANSPLANTATION, 1991, 51 (03) :730-731
[3]  
FELIX JF, 1988, CLIN PHARMACOL THER, V43, P55
[4]   THE IMPACT OF BODY-WEIGHT ON CYCLOSPORINE PHARMACOKINETICS IN RENAL-TRANSPLANT RECIPIENTS [J].
FLECHNER, SM ;
KOLBEINSSON, ME ;
TAM, J ;
LUM, B .
TRANSPLANTATION, 1989, 47 (05) :806-810
[5]  
GREVEL J, 1990, TRANSPLANT P, V22, P1113
[6]   CYCLOSPORINE MONITORING IN RENAL-TRANSPLANTATION - AREA UNDER THE CURVE MONITORING IS SUPERIOR TO TROUGH-LEVEL MONITORING [J].
GREVEL, J ;
WELSH, MS ;
KAHAN, BD .
THERAPEUTIC DRUG MONITORING, 1989, 11 (03) :246-248
[8]   AREA-UNDER-THE-CURVE MONITORING OF CYCLOSPORINE THERAPY - PERFORMANCE OF DIFFERENT ASSAY-METHODS AND THEIR TARGET CONCENTRATIONS [J].
GREVEL, J ;
NAPOLI, KL ;
GIBBONS, S ;
KAHAN, BD .
THERAPEUTIC DRUG MONITORING, 1990, 12 (01) :8-15
[9]   EFFECT OF FOOD ON THE PHARMACOKINETICS OF CYCLOSPORINE IN HEALTHY-SUBJECTS FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION [J].
GUPTA, SK ;
MANFRO, RC ;
TOMLANOVICH, SJ ;
GAMBERTOGLIO, JG ;
GAROVOY, MR ;
BENET, LZ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (07) :643-653
[10]  
IRSCHIK E, 1984, LANCET, V2, P692